Currently, there are 1.63B common shares owned by the public and among those 1.24B shares have been available to trade.
The company’s stock has a 5-day price change of 3.33% and 2.89% over the past three months. MS shares are trading 7.07% year to date (YTD), with the 12-month market performance up to 12.93% higher. It has a 12-month low price of $69.42 and touched a high of $109.11 over the same period. MS has an average intraday trading volume of 6.33 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -0.20%, -0.63%, and 6.78% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Morgan Stanley (NYSE: MS) shares accounts for 61.23% of the company’s 1.63B shares outstanding.
It has a market capitalization of $161.53B and a beta (3y monthly) value of 1.36. The stock’s trailing 12-month PE ratio is 16.44, while the earnings-per-share (ttm) stands at $6.07. The company has a PEG of 0.89 and the debt-to-equity ratio at 3.72. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.03% over the week and 1.96% over the month.
Earnings per share for the fiscal year are expected to increase by 34.97%, and 8.96% over the next financial year. EPS should grow at an annualized rate of 18.45% over the next five years, compared to 1.84% over the past 5-year period.
Wells Fargo coverage for the Morgan Stanley (MS) stock in a research note released on August 02, 2024 offered a Underweight rating with a price target of $95. Oppenheimer was of a view on July 17, 2024 that the stock is Perform, while Keefe Bruyette gave the stock Mkt Perform rating on January 17, 2024, issuing a price target of $102- $91. JP Morgan on their part issued Neutral rating on January 17, 2024.
